News Release
Research Article CiteCleanascite™ on Fatty Acid Influences in Ovarian Cancer CellResponse
MONMOUTHJUNCTION, NJ,September30, 2021 -- Biotech Support Group reports on a research articledescribing the simplicity and efficiency of their lipid depletiontechnology to determine the influence of fatty acids as a source ofenergy in tumors. The citation is:
Wang,Xueyu, et al. "EpigeneticSilencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancerby Modulating the TAK1/FASN/CPT1A/NF-κB Axis." Cancers 13.19(2021): 4795.
The tumor microenvir-onment is known to influence cancer epigenomics, which plays an essential role in promoting tumor development and metastatic progression. To study this, the researchers used ovarian cancer cells cocultured in omental conditioned medium (OCM), which mimics the ascites microenvironment, and in vivo tumor growth. To examine whether fatty acids in OCM are the main source of energy for tumors, all fatty acids in OCM were first removed by CleanasciteTM Lipid Removal Reagent. The article states “The omental mixture was subsequently added to the cell culture medium supplemented with 1% FBS for 24 h. OCM was filtered and stored at 4 °C prior to the removal of omentum tissues by centrifugation. To selectively remove lipids and cell debris, Cleanascite™ … was employed for OCM according to the manufacturer’s suggestions.” XTT cell viability analysis was performed and showed that the cell growth rate of ES-2 and MES-OV cells was remarkably reduced when cocultured in lipid-depleted OCM. The effective use of Cleanascite™ helped establish that “both miR-33b overexpression and depletion of fatty acids by Cleanascite in OCM significantly impaired ovarian cancer cell migration and invasion.” The article concludes that that miR-33b is significantly silenced by DNA hypermethylation in metastatic ovarian cancer cells, to adapt to a lipid-rich microenvironment. Restoration of miR-33b was shown to impair lipid metabolic activities and reduce the oncogenic properties of ovarian cancer cells by negatively regulating the TAK1/FASN/CPT1A/NF-κB pathway, indicating that targeting this signaling cascade may be a molecular therapeutic choice for ovarian cancer metastatic progression.
“Itsvery rewarding to see how Cleanascite™ can enhance cancer researchassociated with the selective removal of fatty acids. Whenever aninvestigation needs to consider whether lipids influence cell cultureresponse, Cleanascite™ can be used. It is an aqueous suspensionproduct without harmful solvents, or any other non-specificcytotoxic effects.This ultimately helps researchers decide whether or not lipids, orfactors interacting with lipids, impart characteristic changes incells. This article exemplifies such utility.” states Swapan Roy,Ph.D., President and Founder of Biotech Support Group
Clickto download whitepaper entitled “Cleanascite™ - Lipid Removaland Cell Response Applications”
Clickto visit Cleanascite™product page and ordering information
AboutBiotech Support Group LLC
Convergingwith cultural and technological disruptions forthcoming inhealthcare, Biotech Support Group develops methods for cost effectiveand efficient sample prep essential for these expanding markets.Following a tiered business strategy, the company continues itsgrowth in the consumable research products area supporting therapidly expanding installation of LC-MS instrument and computationalinfrastructure. For this market, key products include: AlbuVoid™and AlbuSorb™ for albumin depletion, Cleanascite™ for lipidadsorption, HemogloBind™ and HemoVoid™ for hemoglobin removal,the company has acquired knowledgebase and biomarker intellectualproperty assets that support discoveries of protein markers fromblood, with special emphasis on early detection and personalizedmedical decisions for Covid-19 and cancer patients. For moreinformation, go tohttp://www.biotechsupportgroup.com.
ForBusiness Development,contact:MatthewKuruc 732-274-2866, [email protected]